Active Implantable Medical Devices Market by Product Type, and Region - Global Forecast, 2022 - 2028

Active implantable medical devices such as cardiac pacemaker systems, cochlear implants, implantable infusion pumps, cardiac resynchronization therapy devices aid in improving patient’s health and outcome of the medical treatment. Active implantable medical devices are prosthetic devices, which provide support in functioning of organs. For instance, pacemakers and defibrillators are capable of monitoring the heart rhythm. Pacemakers replace the natural pacemaker of the heart i.e. sinoatrial node (SA node) and defibrillator, monitors the heart rhythm and can prevent cardiac arrest. These devices come under Class II and some under Class III devices in the U.S. FDA medical devices listing and are subject to stringent regulations as they pose surgical risks during placement, bruising at surgical site, pain, and high risks due to implant failure. The active implantable medical devices market is dominated by few leading players such as Medtronic Plc., Abbott Laboratories, Boston Scientific Corporation, and Cochlear Ltd. accounting for over 70% of the market share.

Market Dynamics

Advancements in technology such as magnetic resonance imaging (MRI) compatible pacemakers and growing support in favor of use of such devices in cardiovascular and chronic pain diseases is expected to boost growth of the active implantable medical devices market. For instance, in November 2017, American Heart Association (AHA), the American College of Cardiology (ACC), and the Heart Rhythm Society (HRS) approved the use of subcutaneous implantable cardioverter defibrillator, (S-ICD), for the treatment of ventricular arrhythmias and to prevent cardiac arrest. Major manufacturers in the market are focusing on collaborations and mergers and acquisitions and are increasingly investing in research and development of implantable devices. For instance, merger of Sorin Group and Cyberonics to form LivaNova Plc in 2015. Furthermore, effectiveness of these devices in improving medical outcomes of cardiovascular and chronic pain diseases, absence of effective alternatives to these devices and continuous product launches is expected to fuel growth of the market.

Key features of the study:

This report provides in-depth analysis of active implantable medical devices market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global active implantable medical devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans

Key companies covered as a part of this study include Cochlear Limited, Boston Scientific Corporation, Medtronic Plc, LivaNova Plc, Abbott laboratories, Sonova Holding AG, William Demant holding A/S, Nurotron Biotechnology Co., Ltd., and Med-EL

Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics

The global active implantable medical devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the active implantable medical devices market

Detailed Segmentation:

Global Active Implantable Medical Devices Market, By Product Type:

Pacemakers

Implantable Cardioverter Defibrillators (ICD)

Cardiac Resynchronization Therapy Devices (CRT-D)

Neurostimulators

Drug Infusion Pumps

Implantable Loop Recorders

Cochlear Implants

Others

Global Active Implantable Medical Devices Market, By Geography:

North America

By Product Type:

Pacemakers

Implantable Cardioverter Defibrillators (ICD)

Cardiac Resynchronization Therapy Devices (CRT-D)

Neurostimulators

Drug Infusion Pumps

Implantable Loop Recorders

Cochlear Implants

Others

By Country:

U.S.

Canada

Europe

By Product Type:

Pacemakers

Implantable Cardioverter Defibrillators (ICD)

Cardiac Resynchronization Therapy Devices (CRT-D)

Neurostimulators

Drug Infusion Pumps

Implantable Loop Recorders

Cochlear Implants

Others

By Country:

U.K.

Germany

Italy

France

Spain

Russia

Rest of Europe

Asia Pacific

By Product Type:

Pacemakers

Implantable Cardioverter Defibrillators (ICD)

Cardiac Resynchronization Therapy Devices (CRT-D)

Neurostimulators

Drug Infusion Pumps

Implantable Loop Recorders

Cochlear Implants

Others

By Country:

China

India

Japan

ASEAN

Australia

South Korea

Rest of Asia Pacific

Latin America

By Product Type:

Pacemakers

Implantable Cardioverter Defibrillators (ICD)

Cardiac Resynchronization Therapy Devices (CRT-D)

Neurostimulators

Drug Infusion Pumps

Implantable Loop Recorders

Cochlear Implants

Others

By Country:

Brazil

Mexico

Rest of Latin America

Middle East

By Product Type:

Pacemakers

Implantable Cardioverter Defibrillators (ICD)

Cardiac Resynchronization Therapy Devices (CRT-D)

Neurostimulators

Drug Infusion Pumps

Implantable Loop Recorders

Cochlear Implants

Others

By Country:

GCC

Israel

Rest of Middle East

Africa

By Product Type:

Pacemakers

Implantable Cardioverter Defibrillators (ICD)

Cardiac Resynchronization Therapy Devices (CRT-D)

Neurostimulators

Drug Infusion Pumps

Implantable Loop Recorders

Cochlear Implants

Others

By Country:

Central Africa

South Africa

North Africa

Company Profiles

Cochlear Limited*

Company Overview

Product Portfolio

Financial Performance

Key Strategies

Recent Developments

Boston Scientific Corporation

Medtronic Plc.

LivaNova Plc.

Abbott Laboratories

Sonova Holding AG

William Demant holding A/S

Nurotron Biotechnology Co. Ltd.

Med-EL

 “*” marked represents similar segmentation in other categories in the respective section.